login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANAVEX LIFE SCIENCES CORP (AVXL) Stock News
USA
-
Nasdaq
- NASDAQ:AVXL -
US0327973006
-
Common Stock
4.14
USD
+0.12 (+2.99%)
Last: 12/15/2025, 8:06:31 PM
4.14
USD
0 (0%)
After Hours:
12/15/2025, 8:06:31 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AVXL Latest News, Press Relases and Analysis
All
Press Releases
21 days ago - By: Chartmill
Anavex Life Sciences Corp (NASDAQ:AVXL) Surges on Better-Than-Expected Q4 2025 Earnings
3 days ago - By: Stocktwits
- Mentions:
IWMW
EAOR
ORCL
Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential
3 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
5 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
6 days ago - By: Schall Law
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
12 days ago - By: The Schall Law Firm
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
14 days ago - By: Zacks Investment Research
Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL)
20 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
20 days ago - By: The Motley Fool
Anavex (AVXL) Q4 2025 Earnings Call Transcript
20 days ago - By: Stocktwits
- Mentions:
IWMW
EAOR
AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug
21 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
a month ago - By: Stocktwits
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'
a month ago - By: Benzinga
- Mentions:
PTN
ZYXI
CDTX
CMND
...
12 Health Care Stocks Moving In Friday's Intraday Session
a month ago - By: Benzinga
- Mentions:
VSTM
TSSI
SEI
RCAT
...
Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease
a month ago - By: Stocktwits
AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug
a month ago - By: Stocktwits
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug?
a month ago - By: Stocktwits
- Mentions:
IWMW
EAOR
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
2 months ago - By: Stocktwits
Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
2 months ago - By: Stocktwits
- Mentions:
EAOR
ITOT
Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
Please enable JavaScript to continue using this application.